Grifols is a global healthcare company with its origins dating back to its founding in Barcelona in 1909. We are deeply committed to improving the health and well-being of individuals worldwide.

As leaders in essential plasma-derived medicines and transfusion medicine, we are dedicated to the development, production, and provision of innovative healthcare services and solutions across more than 110 countries. Our relentless focus on patient needs, combined with our ever-expanding knowledge of various chronic, rare, and prevalent diseases—some of which are life-threatening—drives our innovation in plasma-based therapies and other biopharmaceuticals, ultimately enhancing the quality of life.

Grifols is dedicated to addressing a wide spectrum of medical conditions, including those in the fields of immunology, hepatology and intensive care, pulmonology, hematology, neurology, and infectious diseases.

With a global workforce exceeding 27,000 employees across more than 30 countries and regions, we uphold a commitment to a sustainable business model that establishes industry standards in continuous innovation, quality, safety, and ethical leadership. Our work has a meaningful social and economic impact in the communities where we operate, creating employment opportunities and contributing to economic growth.

People are at the core of our mission, and we strive to foster an inclusive, diverse, equitable, and fair society. Cultivating and promoting a workforce that mirrors this reality fosters stronger professional relationships and empowers us to provide our best to patients, donors, and customers.

In 2022, Forbes recognized Grifols as one of the ""Best Employers for Women,"" one of ""America's Best Large Employers,"" and one of the ""75 Best Companies to Work for"" in Spain.